Stock Price
14.62
Daily Change
-0.43 -2.86%
Monthly
8.30%
Yearly
28.81%
Q1 Forecast
14.47

Amarin reported $0.08 in EPS Earnings Per Share for its fiscal quarter ending in September of 2025.





Eps Change Date
AbbVie USD 2.71 0.85 Dec/2025
Alnylam Pharmaceuticals USD 2.9 2.58 Sep/2025
Amarin USD 0.08 0.11 Sep/2025
AstraZeneca USD 2.38 0.21 Sep/2025
DBV Technologies USD -0.24 1.31 Sep/2025
GlaxoSmithKline GBP 0.26 0.29 Dec/2025
Halozyme Therapeutics USD 1.72 0.18 Sep/2025
Ionis Pharmaceuticals USD -0.8 1.5 Sep/2025
Neurocrine Biosciences USD 2.17 0.52 Sep/2025
Novartis USD 2.04 0.38 Sep/2025